Dr Reddy's Board Approves Q2 & H1 FY27 Unaudited Financial Results

Dr Reddy's Laboratories Ltd. announced the outcome of its Board meeting held on October 23, 2026. The Board approved the unaudited financial results for the quarter and half-year ended September 30, 2026, including consolidated and standalone statements prepared under IFRS and Ind AS, along with auditor's limited review reports. Additionally, the Board approved the appointment of Mr. Akhil Ravi as Head API and Services and Senior Management Personnel, effective November 13, 2026. Mr. Ravi is the son-in-law of Co-Chairman & MD, G V Prasad.